Valentina Zorina

Mrs. Valentina Zorina

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2025 in The Russian Archives of Internal Medicine
Verified
Journal Article
Open access
PDF file
VZValentina Zorina
Valentina Zorina
AKA. A. Karaseva
A. A. Karaseva
Evgeniia Garbuzova (Striukova)Evgeniia Garbuzova (Striukova)
Evgeniia Garbuzova (Striukova)
AAA. D. Afanasyeva
A. D. Afanasyeva
SDS. V. Duma
S. V. Duma
Yuliya RaginoYuliya Ragino
Yuliya Ragino
Aim. To study the characteristics of the neuropsychiatric phenotype of postCOVID syndrome in COVID-19 convalescents. Materials and methods. A sample of 270 COVID-19 convalescents (mean age — 53.2±13.2, (n=130, 48.1 % men)): 62 (23.0 %) without postCOVID syndrome and 208 (77.0 %) with postCOVID syndrome. In the subgroup with postCOVID syndrome, 134 (64.4 %) convalescents had a neuropsychiatric phenotype. The study took into account medical history data, assessed the neuropsychiatric status on the following scales: Hospital Anxiety and Depression Scale (HADS), Multidimensional Fatigue Inventory (MFI-20), Symptom Checklist-90-Revised (SCL-90), 36-Item Short-Form Health Survey (SF-36), all patients were consulted by a neurologist, a somnologist and a therapist. Results. The structure of the neuropsychiatric phenotype: insomnia (n=74, 55.2 %), severe asthenia (MFI-20 scale, n=55, 41.0 %), anxiety and depression (HADS scale, n=37, 27.6 %, n=32, 23.9 %, respectively), anosmia/dysosmia (n=13.9.7 %), ageusia/dysgeusia (n=6, 4.5 %). According to the SF-36 questionnaire, in the group of people with a neuropsychiatric phenotype, a marked decrease in indicators was detected in all subscales. According to the SCL-90-R questionnaire, the group with the neuropsychiatric phenotype showed a marked increase in all subscales. The following features were noted in women with a neuropsychiatric phenotype: indicators were lower on the scales: physical functioning by 1.1 times (p=0.017), role-playing functioning due to physical condition by 1.6 times (p=0.031) (SF-36 scale), indicators of obsessive-compulsive disorder by 1.7 times higher (p=0.028), depression 1.5 times (p=0.005), anxiety 2 times (p=0.017) (SCL-90 scale), according to the results of the HADS scale assessment, the incidence of depression in women with the neuropsychiatric phenotype of postCOVID syndrome is 3 times higher (p=0.043) compared with men, having the same phenotype. Conclusion. The neuropsychiatric phenotype of postCOVID syndrome is characterized by the presence of insomnia, severe asthenia, anxiety, depressive disorders, anosmia/dysosmia, and ageusia/dysgeusia. Individuals with a neuropsychiatric phenotype have reduced indicators of quality of life and the level of psychological well-being of the individual in all subscales, according to the SF-36 and SCL-90-R questionnaires. The incidence of neuropsychiatric phenotype, as well as the severity of psychopathological symptoms, is higher in the group of women.

17 June 2024 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
AIA. A. Ivanova
A. A. Ivanova
EMElizaveta Melnikova
Elizaveta Melnikova
VZValentina Zorina
Valentina Zorina
AGA. A. Gurazheva
A. A. Gurazheva
SMS. V. Maksimova
S. V. Maksimova
Vladimir Nikolaevich MaksimovVladimir Nikolaevich Maksimov
Vladimir Nikolaevich Maksimov
BACKGROUND: Obesity is a widespread disease associated with serious complications. Obesity is a risk factor for many chronic diseases. The most common type of obesity is polygenic obesity, the pathogenesis of which involves external and internal factors, including genetic ones.AIM: Search and study of the association of variants of the nucleotide sequence rs9939609 of the FTO gene, rs7903146 of the TCF7L2 gene, rs1799883 of the FABP2 gene, rs1800497 of the DRD2 gene, rs17782313 of the MC4R gene with morbid obesity in women.MATERIALS AND METHODS: Study design is case-control study. The morbid obesity group and the control group were formed from the DNA bank of participants of the international project HAPIEE. Genotyping was performed by PCR-RFLP and real-time PCR (TaqMan probes, Applied Biosystems, USA). Statistical analysis was performed in SPSS software using Pearson’s chi-square test, Fisher’s exact two-tailed test with Yates’ correction for continuity. The significance level was used p0.05). In the group of morbid obesity, the proportion of carriers of the TT genotype rs9939609 of the FTO gene was statistically significantly lower, and the AT genotype was significantly higher than in the control group (OR=0.579, 95% CI 0.399-0.840, p=0.004; OR=1.408, 95% CI 1.003- 1.976, p=0.047, respectively). The heterozygous TC genotype rs17782313 of the MC4R gene is statistically significantly more common (OR=1.825, 95% CI 1.257-2.652, p=0.002), while the homozygous TT genotype is less common (OR=0.500, 95% CI 0.346-0.723, p<0.001) in group of morbid obesity compared with the control group.CONCLUSION: Heterozygous genotypes of the rs9939609 of the FTO gene (AT) and rs17782313 of the MC4R gene (TC) are risk genotypes; the homozygous genotype TT of the variants is protective for morbid obesity in women. Single nucleotide variants rs7903146 of the TCF7L2 gene, rs1799883 of the FABP2 gene, and rs1800497 of the DRD2 gene are not associated with morbid obesity in women.

23 April 2024 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
VZValentina Zorina
Valentina Zorina
Evgeniia Garbuzova (Striukova)Evgeniia Garbuzova (Striukova)
Evgeniia Garbuzova (Striukova)
AAA.D. Afanaseva
A.D. Afanaseva
ESElena Shakhtshneider
Elena Shakhtshneider
ILI.I. Logvinenko
I.I. Logvinenko
Objective. To study the association of post-Covid syndrome (PCS) phenotypes with cardiometabolic risk factors. Material and methods. The sample included 270 patients recovering after a new coronavirus infection (COVID-19), 79 without PCS and 191 with PCS. The research considered the anamnesis data, anthropometry, blood pressure (BP) level, clinical and biochemical blood, and clinical urine test parameters. The findings were statistically processed using the SPSS software package (version 13.0). Results. The indicators that were higher in the PCS group included age — by 1.2 times (p=0.001), BMI — by 1.1 times (p=0.002), waist circumference — by 1.1 times (p=0.001), systolic arterial pressure — by 1.1 times (p=0.021), fasting plasma glucose — by 1.1 times (p<0.001). Cardiovascular diseases before the onset of COVID-19 were 3.2 times more common in the PCS group (p=0.013). Only patients with PCS had a severe acute period of COVID-19. All patients with PCS were divided into 6 phenotypic groups: mixed — 39.8%, cardiovascular — 4.2%, bronchopulmonary — 1.0%, psychoneurological — 26.2%, endocrine — 22.5%, and alopecia — 6.3% phenotype. Conclusion. Convalescents with post-COVID syndrome had higher values of age, BMI, waist circumference, systolic arterial pressure, fasting plasma glucose, and the presence of cardiovascular diseases before COVID-19. Only patients with post-Covid syndrome had a severe acute period of COVID-19. Six phenotypic groups were identified in convalescents with post-COVID syndrome.

30 December 2025 in Ateroscleroz
Verified
Journal Article
Closed access
APA. V. Pavlova
A. V. Pavlova
SMS. S. Mestnikova
S. S. Mestnikova
SES. S. Everstova
S. S. Everstova
AAA. S. Asekritova
A. S. Asekritova
OTO. V. Tatarinova
O. V. Tatarinova
ESElena Shakhtshneider
Elena Shakhtshneider
The aim of the study. Molecular genetic studies of familial hypercholesterolemia (FH) have been conducted in different regions of the Russian Federation for several decades. However, limited ethnic diversity in patient samples does not permit a comprehensive assessment of the full spectrum of gene variability responsible for FH development in the Russian population. The aim of this study was to characterize the molecular heterogeneity of the LDLR and APOB genes in patients with FH phenotype in the Republic of Sakha (Yakutia). Material and methods. A group of 48 patients with FH was enrolled at the Department of Lipid Disorders, Republican Clinical Hospital No. 3, Yakutsk. FH diagnosis was established using the Dutch Lipid Clinic Network (DLCN) Criteria. All patients underwent clinical examination, ultrasonographic evaluation, and blood sampling for biochemical and molecular genetic analyses. Molecular variants in index patients and segregation analysis in available family members were identified using direct automated Sanger sequencing of the LDLR gene promoter and all exons, as well as exon 26 of the APOB gene. Results. Pathogenic variants in the LDLR gene were identified in three index patients with the FH phenotype. Segregation analysis in families of index patients identified three additional carriers of the rs121908038 variant among first-degree relatives. Based on direct automated sequencing of exon 26 of the APO B gene, a pathogenic variant (rs5742904) was identified in one index patient and three of his first-degree relatives. Conclusions. Molecular genetic analysis of the LDLR gene and exon 26 of the APOB gene in patients with the FH phenotype from the Republic of Sakha (Yakutia) identified pathogenic variants in two genes. Heterozygous familial hypercholesterolemia was confirmed in index patients and segregated among first-degree relatives. These findings underscore the importance of genetic testing and family screening in FH diagnosis and management.

1 January 2025 in Therapist’s Bulletin
Verified
Journal Article
Closed access
VZValentina Zorina
Valentina Zorina
RNRussian Federation Novosibirsk
Russian Federation Novosibirsk
AAA.D. Afanaseva
A.D. Afanaseva
SMSvetlana Vladimirovna Mustafina
Svetlana Vladimirovna Mustafina
ESE.V. Shakhtschneider
E.V. Shakhtschneider
ILI.I. Logvinenko
I.I. Logvinenko
Aim. To study the clinical and laboratory characteristics of the endocrine phenotype of post-COVID syndrome. Design. A one-stage observational study. Materials and methods. A sample of 270 COVID-19 convalescents was examined. Based on the criteria of the World Health Organization, a group with post-COVID syndrome was identified, comprising 208 convalescents, of whom 98 had the endocrine phenotype. The study included the assessment of medical history, analysis of medical records, anthropometric measurements, and a range of clinical and biochemical blood parameters. All patients were evaluated by an internist and relevant specialist physicians. Results Individuals with the endocrine phenotype of post-COVID syndrome had higher values of the following parameters compared to patients with other phenotypes: age (p < 0.001), body mass index (p < 0.001), waist circumference (p < 0.001), systolic blood pressure (p = 0.010), triglyceride levels (p = 0.002), and uric acid levels (p < 0.001). They also demonstrated lower levels of high-density (p = 0.031) and low-density (p = 0.049) lipoprotein cholesterol, as well as a reduced glomerular filtration rate (p < 0.001). In the endocrine phenotype, the following conditions were more frequently diagnosed: obesity (based on body mass index) (p = 0.010), abdominal obesity (p < 0.001), arterial hypertension (p < 0.001), hypertriglyceridemia (p = 0.026), hyperuricemia (p < 0.001), and a decreased glomerular filtration rate < 90 mL/min/1.73 m2 (p = 0.016). Multivariate regression analysis showed that, in men older than 45 years, the presence of the endocrine phenotype of post-COVID syndrome was directly associated with a reduced glomerular filtration rate < 90 mL/min/1.73 m2 (odds ratio (OR) = 8.311; 95% confidence interval (CI): 1.628–42.442; p = 0.011), whereas in women older than 45 years it was associated with an increase in uric acid level by 1 µmol/L (OR = 1.010; 95% CI: 1.002–1.019; p = 0.014). Conclusion. The prevalence of the endocrine phenotype of post-COVID syndrome was 47.1% (52.0% in men and 48.0% in women). Individuals with the endocrine phenotype more frequently had a history of severe COVID-19 and glucocorticoid therapy. In men older than 45 years, the likelihood of having the endocrine phenotype of post-COVID syndrome was associated with reduced glomerular filtration rate, whereas in women older than 45 years it was associated with increased uric acid levels. Keywords: convalescences of COVID-19, post-COVID syndrome, endocrine phenotype.

28 December 2023 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
VZValentina Zorina
Valentina Zorina
AAAlena Afanaseva
Alena Afanaseva
Evgeniia Garbuzova (Striukova)Evgeniia Garbuzova (Striukova)
Evgeniia Garbuzova (Striukova)
ЦЕЛЬ СИСТЕМАТИЧЕСКОГО ОБЗОРА Анализ ассоциации генетических маркеров с различными формами течения COVID-19 у человека. МАТЕРИАЛ И МЕТОДЫ Для поиска литературы использованы поисковые системы eLIBRARY.RU — научная электронная библиотека и PubMed.gov. Условиями включения стали: возраст пациентов от 18 лет, положительный результат обнаружения нуклеиновой кислоты SARS-CoV-2 в образцах пациентов методом полимеразной цепной реакции с обратной транскриптазой, ранжирование пациентов по степеням тяжести течения инфекции COVID-19. В данном анализе рассмотрены только публикации последних 3 лет (2020—2022 гг.) и не включались клинические исследования препаратов, исследования, проведенные на животных, и обзоры литературы. РЕЗУЛЬТАТЫ Анализ литературы за 2020—2022 гг. показал, что в большинстве случаев исследования направлены на изучение генетических маркеров вируса. Авторы делают акцент на поиске ассоциаций с тяжелым течением COVID-19. Остаются малозаметными бессимптомные случаи заболевания, которые также приводят к серьезным последствиям в социальной и экономической сфере общества ввиду распространения инфекции. В проанализированной литературе основная масса исследований направлена на изучение ассоциации степеней тяжести течения COVID-19 и вариантов нуклеотидной последовательности генов HLA, ACE2, TMPRSS2, LZTFL1. Данные гены являются перспективными для дальнейшего изучения, результаты которого могут внести большой вклад в стратификацию рисков, оптимизацию профилактики и разработку персонализированного лечения. ЗАКЛЮЧЕНИЕ Анализ литературы позволяет нам включить генетические маркеры в факторы риска течения инфекции COVID-19. Однако современные исследования имеют ряд ограничений: небольшие размеры выборки, ограничение исследований только одной популяцией, разные интерпретации степеней тяжести.